|
|
 |
|
Total Number of Holdings (excluding cash): 50
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$80,155.74 |
2.35% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$79,877.22 |
2.35% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$77,094.57 |
2.26% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$76,707.14 |
2.25% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$76,188.80 |
2.24% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$75,813.62 |
2.23% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$75,321.63 |
2.21% |
| Steris Plc |
STE |
G8473T100 |
298 |
$75,185.40 |
2.21% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$75,411.73 |
2.21% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$75,275.97 |
2.21% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$74,798.91 |
2.20% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$74,368.00 |
2.18% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$74,238.99 |
2.18% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$73,734.24 |
2.17% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$73,601.40 |
2.16% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$73,453.74 |
2.16% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$73,335.36 |
2.15% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$72,653.51 |
2.13% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$71,420.57 |
2.10% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$70,815.66 |
2.08% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$70,575.06 |
2.07% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$70,339.67 |
2.07% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$70,608.15 |
2.07% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$70,565.02 |
2.07% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$70,363.28 |
2.07% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$69,966.75 |
2.05% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$69,299.23 |
2.03% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$68,637.62 |
2.02% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$68,372.80 |
2.01% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$67,750.33 |
1.99% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$67,428.55 |
1.98% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$67,391.72 |
1.98% |
| Waters Corporation |
WAT |
941848103 |
147 |
$67,267.20 |
1.98% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$67,002.75 |
1.97% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$66,774.75 |
1.96% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$65,535.00 |
1.92% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$65,413.40 |
1.92% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$64,210.18 |
1.89% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$64,370.65 |
1.89% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$63,996.75 |
1.88% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$64,145.77 |
1.88% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$63,939.59 |
1.88% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$63,842.00 |
1.87% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$60,889.85 |
1.79% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$60,351.60 |
1.77% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$58,698.47 |
1.72% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$55,671.34 |
1.63% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$55,425.86 |
1.63% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,576.10 |
1.31% |
| US Dollar |
$USD |
|
23,124 |
$23,123.50 |
0.68% |
| Japanese Yen |
$JPY |
|
42,336 |
$267.05 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
| Pound Sterling |
$GBP |
|
-410 |
($546.60) |
-0.02% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|